CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,383,812
- in 18 filings, $13.4M under 10b5-1 plans
Net −$32,383,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-01 | LO FRANCIS Chief People Officer | Sale 10b5-1 | −8,743 | $22.18 | $194K | 279,949 |
| 2026-07-01 | LO FRANCIS Chief People Officer | Sale 10b5-1 | −42,261 | $22.50 | $951K | 237,688 |
| 2026-07-01 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −3,500 | 72,000 | ||
| 2026-07-01 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −3,300 | 168,523 | ||
| 2026-07-01 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −12,206 | 72,859 | ||
| 2026-07-01 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −4,688 | 81,265 | ||
| 2026-07-01 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −14,064 | 126,584 | ||
| 2026-06-29 | BENZENO SHARON Chief Commercial Ofc Imm Med | Option exercise 10b5-1 | +1,837 | $12.14 | $22K | 274,588 |
| 2026-06-29 | BENZENO SHARON Chief Commercial Ofc Imm Med | Option exercise 10b5-1 | +24,944 | $8.46 | $211K | 299,532 |
| 2026-06-29 | BENZENO SHARON Chief Commercial Ofc Imm Med | Option exercise 10b5-1 | +24,944 | $3.99 | $100K | 324,476 |
| 2026-06-29 | BENZENO SHARON Chief Commercial Ofc Imm Med | Option exercise 10b5-1 | +51,570 | $8.12 | $419K | 376,046 |
| 2026-06-29 | BENZENO SHARON Chief Commercial Ofc Imm Med | Sale 10b5-1 | −154,768 | $21.14 | $3.3M | 221,278 |
| 2026-06-29 | BENZENO SHARON Chief Commercial Ofc Imm Med | Option exercise · Stock Option (right to buy) 10b5-1 | −1,837 | 0 | ||
| 2026-06-29 | BENZENO SHARON Chief Commercial Ofc Imm Med | Option exercise · Stock Option (right to buy) 10b5-1 | −24,944 | 37,416 | ||
| 2026-06-29 | BENZENO SHARON Chief Commercial Ofc Imm Med | Option exercise · Stock Option (right to buy) 10b5-1 | −24,944 | 87,303 | ||
| 2026-06-29 | BENZENO SHARON Chief Commercial Ofc Imm Med | Option exercise · Stock Option (right to buy) 10b5-1 | −51,570 | 113,457 | ||
| 2026-06-26 | BENZENO SHARON Chief Commercial Ofc Imm Med | Option exercise 10b5-1 | +11,034 | $12.14 | $134K | 283,785 |
| 2026-06-26 | BENZENO SHARON Chief Commercial Ofc Imm Med | Sale 10b5-1 | −11,034 | $21.00 | $232K | 272,751 |
| 2026-06-26 | BENZENO SHARON Chief Commercial Ofc Imm Med | Option exercise · Stock Option (right to buy) 10b5-1 | −11,034 | 1,837 | ||
| 2026-06-25 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale 10b5-1 | −5,000 | $20.50 | $103K | 406,775 |
Page 10 of 119 · 2,375 trades